We are live on ! Find out more
TS

Triglav Skladi Portfolio holdings

AUM $1.43B
1-Year Est. Return 39.24%
This Fund
S&P 500
This Quarter Est. Return
+6.79%
1 Year Est. Return
+39.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.27B
AUM Growth
–
Cap. Flow
+$1.26B
Cap. Flow %
99.29%
Top 10 Hldgs %
50.32%
Holding
124
New
124
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$117M
2
MSFT icon
Microsoft
MSFT
+$90.7M
3
AMZN icon
Amazon
AMZN
+$84.6M
4
AAPL icon
Apple
AAPL
+$80.3M
5
META icon
Meta Platforms (Facebook)
META
+$62M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 34.39%
2 Consumer Discretionary 13.94%
3 Healthcare 13.73%
4 Communication Services 13.59%
5 Financials 13.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
76
Regeneron Pharmaceuticals
REGN
$79.5B
$1.79M 0.14%
+2,515
New +$2.11M
DE icon
77
Deere & Co
DE
$166B
$1.72M 0.14%
+4,049
New +$1.71M
RMD icon
78
ResMed
RMD
$32.4B
$1.69M 0.13%
+7,400
New +$1.78M
SNPS icon
79
Synopsys
SNPS
$77.7B
$1.65M 0.13%
+3,405
New +$1.78M
BMY icon
80
Bristol-Myers Squibb
BMY
$131B
$1.63M 0.13%
+28,900
New +$1.61M
FDX icon
81
FedEx
FDX
$74.7B
$1.59M 0.13%
+5,660
New +$1.58M
INCY icon
82
Incyte
INCY
$24B
$1.59M 0.13%
+23,000
New +$1.64M
SYY icon
83
Sysco
SYY
$40.4B
$1.53M 0.12%
+20,000
New +$1.53M
NEE icon
84
NextEra Energy
NEE
$176B
$1.52M 0.12%
+21,151
New +$1.64M
NBIX icon
85
Neurocrine Biosciences
NBIX
$16.2B
$1.5M 0.12%
+11,000
New +$1.36M
EW icon
86
Edwards Lifesciences
EW
$51.5B
$1.49M 0.12%
+20,060
New +$1.4M
GILD icon
87
Gilead Sciences
GILD
$162B
$1.48M 0.12%
+16,000
New +$1.44M
MDT icon
88
Medtronic
MDT
$110B
$1.48M 0.12%
+18,499
New +$1.6M
DAR icon
89
Darling Ingredients
DAR
$9.62B
$1.45M 0.11%
+43,125
New +$1.63M
DXCM icon
90
DexCom
DXCM
$31.3B
$1.44M 0.11%
+18,500
New +$1.37M
ILMN icon
91
Illumina
ILMN
$29.3B
$1.4M 0.11%
+10,500
New +$1.5M
VRTX icon
92
Vertex Pharmaceuticals
VRTX
$123B
$1.39M 0.11%
+3,450
New +$1.6M
SRPT icon
93
Sarepta Therapeutics
SRPT
$1.77B
$1.34M 0.11%
+11,000
New +$1.35M
DELL icon
94
Dell
DELL
$283B
$1.21M 0.1%
+10,500
New +$1.32M
AMGN icon
95
Amgen
AMGN
$219B
$1.17M 0.09%
+4,500
New +$1.34M
PANW icon
96
Palo Alto Networks
PANW
$293B
$1.09M 0.09%
+6,000
New +$1.13M
BMRN icon
97
BioMarin Pharmaceuticals
BMRN
$11.9B
$1.08M 0.09%
+16,500
New +$1.11M
IQV icon
98
IQVIA
IQV
$38.3B
$1.08M 0.09%
+5,500
New +$1.16M
SFM icon
99
Sprouts Farmers Market
SFM
$8.13B
$1.07M 0.08%
+8,400
New +$1.12M
LRCX icon
100
Lam Research
LRCX
$383B
$1.07M 0.08%
+14,750
New +$1.12M
1 2 3
4
5

Similar funds

SCA
Stonebridge Capital Advisors St Paul, Minnesota $1.43B AUM 21.98% 1-Year Est. Return
CCM
Callodine Capital Management Boston, Massachusetts $1.43B AUM 8.74% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 28.88% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
WIM
Weitz Investment Management Omaha, Nebraska $1.43B AUM 0.51% 1-Year Est. Return

Triglav Skladi's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Triglav Skladi, which disclosed 124 positions worth $1.27B. Its ten largest holdings account for 50% of the portfolio.

Its largest position is NVIDIA: 850,882 shares worth $114M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, followed by Consumer Discretionary and Healthcare.

  • Triglav Skladi's largest Q4 2024 buy was NVIDIA: 850,882 shares worth $114M.
  • Triglav Skladi's ten largest holdings make up 50% of its $1.27B portfolio in Q4 2024.
  • Triglav Skladi disclosed 124 positions in Q4 2024, its first 13F filing on record.

Based on Triglav Skladi's 13F filing for Q4 2024, filed 14 Feb 2025.